mutations and complex kar yotype. It follows a linear evolution through the CLL clone from the recurrent acquisition of CDKN2ANot all individuals with CLL have to have therapy. Inspite of all the latest advances, the iwCLL even now endorses watchful observation for patients with asymptomatic illness.86 This advice is predicated on at least two rand… Read More